What does DERMPAT do?

DERMPAT is a specialist medical practice in Gent. Private Limited, started on 22 December 2011, 1 establishment.

What is the address of DERMPAT?

The registered office of DERMPAT is located at Koning Albertlaan 210, 9000 Gent.

Is DERMPAT still active?

Yes. According to the CBE (29 October 2026) DERMPAT is active, legal situation “Normale toestand”, started on 22 December 2011.

Is DERMPAT registered on Peppol?

Yes, DERMPAT is registered on the Peppol network with ID 0208:0842445493.

What is the enterprise number of DERMPAT?

The enterprise number of DERMPAT is BE0842445493.

When was DERMPAT founded?

DERMPAT was founded on 22 December 2011.

Who are the directors of DERMPAT?

According to the 2025 annual accounts, the directors of DERMPAT are: Integron BV, Nessence BV, Patholem BV, Dr. Karolien Van Den Bossche BV.

Is DERMPAT a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 22 December 2011; 5 annual accounts filed, latest fiscal year 2025; 4 directors known from the annual account.

How much profit did DERMPAT make in 2025?

DERMPAT posted a profit after taxes of € 46,857 in financial year 2025.

What is the revenue of DERMPAT?

As a small company, DERMPAT is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 1,053,290.

How much does an employee at DERMPAT earn?

The average wage cost per full-time employee at DERMPAT was € 69,600 in 2025: staff costs of € 793,263 for 11.4 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does DERMPAT have?

According to the 2025 annual accounts, DERMPAT has 11.4 full-time equivalents (FTE).

DERMPAT (Private Limited) - Gent - BE0842445493

Dossier DERMPAT, printed on 29 October 2026 from databakkes.be/en/0842445493/dermpat. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

DERMPAT from Gent, company number BE0842445493, closed financial year 2025 with a result of € 46,857 after tax. For that financial year DERMPAT recorded a gross margin of € 1.1 million and equity of € 595,946. Compared with financial year 2024, the result moved from € 184,668 to € 46,857. The company is profitable. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on May 20, 2026.

What it is worth Healthy

€ 595,946

▼ 20% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 46,857

▼ 75% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 236,515

▼ 24% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 150,000 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Full-time equivalents

11.4

▲ 2.3 vs 2024

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 793,263

▲ 37% vs 2024

€ 69,600 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 275,453

▲ 221% vs 2024

Of which on lease € 272,012.

Debts at end 2025

Bank debt ≈ 4 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 262,190

▲ 225% vs 2024

€ 72,275 is repaid this year. At this pace the long-term loan is gone in ≈ 4 years.

Owed to suppliers

€ 55,107

▼ 54% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Wages and social charges

€ 73,125

▼ 23% vs 2024

Wages, holiday pay and social contributions still to pay. No outstanding taxes.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 591,548 Gross margin 2022: € 591,548 First fiscal year in the series	€ 680,985 Gross margin 2023: € 680,985 ▲ 15% vs 2022 (€ 591,548) Favourable step	€ 958,727 Gross margin 2024: € 958,727 ▲ 41% vs 2023 (€ 680,985) Favourable step	€ 1,053,290 Gross margin 2025: € 1,053,290 ▲ 10% vs 2024 (€ 958,727) Favourable step	▲ 10%
Profit after taxes	€ 64,738 Profit after taxes 2022: € 64,738 First fiscal year in the series	€ 70,131 Profit after taxes 2023: € 70,131 ▲ 8% vs 2022 (€ 64,738) Favourable step	€ 184,668 Profit after taxes 2024: € 184,668 ▲ 163% vs 2023 (€ 70,131) Favourable step	€ 46,857 Profit after taxes 2025: € 46,857 ▼ 75% vs 2024 (€ 184,668) Unfavourable step	▼ 75%
Equity	€ 556,969 Equity 2022: € 556,969 First fiscal year in the series	€ 599,109 Equity 2023: € 599,109 ▲ 8% vs 2022 (€ 556,969) Favourable step	€ 744,352 Equity 2024: € 744,352 ▲ 24% vs 2023 (€ 599,109) Favourable step	€ 595,946 Equity 2025: € 595,946 ▼ 20% vs 2024 (€ 744,352) Unfavourable step	▼ 20%
Total debts	€ 297,601 Total debts 2022: € 297,601 First fiscal year in the series	€ 277,338 Total debts 2023: € 277,338 ▼ 7% vs 2022 (€ 297,601) Favourable step	€ 452,393 Total debts 2024: € 452,393 ▲ 63% vs 2023 (€ 277,338) Unfavourable step	€ 556,346 Total debts 2025: € 556,346 ▲ 23% vs 2024 (€ 452,393) Unfavourable step	▲ 23%
Cash	€ 306,025 Cash 2022: € 306,025 First fiscal year in the series	€ 109,127 Cash 2023: € 109,127 ▼ 64% vs 2022 (€ 306,025) Unfavourable step	€ 311,112 Cash 2024: € 311,112 ▲ 185% vs 2023 (€ 109,127) Favourable step	€ 236,515 Cash 2025: € 236,515 ▼ 24% vs 2024 (€ 311,112) Unfavourable step	▼ 24%
Land & buildings	€ 79,412 Land & buildings 2022: € 79,412 First fiscal year in the series	€ 70,080 Land & buildings 2023: € 70,080 ▼ 12% vs 2022 (€ 79,412) Unchanged	€ 52,527 Land & buildings 2024: € 52,527 ▼ 25% vs 2023 (€ 70,080) Unchanged	€ 33,223 Land & buildings 2025: € 33,223 ▼ 37% vs 2024 (€ 52,527) Unchanged	▼ 37%
Retained profit	€ 396,969 Retained profit 2022: € 396,969 First fiscal year in the series	€ 439,109 Retained profit 2023: € 439,109 ▲ 11% vs 2022 (€ 396,969) Favourable step	€ 584,352 Retained profit 2024: € 584,352 ▲ 33% vs 2023 (€ 439,109) Favourable step	€ 435,946 Retained profit 2025: € 435,946 ▼ 25% vs 2024 (€ 584,352) Unfavourable step	▼ 25%
Dividend	€ 3,000 Dividend 2022: € 3,000 First fiscal year in the series	€ 6,000 Dividend 2023: € 6,000 ▲ 100% vs 2022 (€ 3,000) Unchanged	€ 7,500 Dividend 2024: € 7,500 ▲ 25% vs 2023 (€ 6,000) Unchanged	€ 150,000 Dividend 2025: € 150,000 ▲ € 142,500 vs 2024 (€ 7,500) Unchanged	▲ € 142,500
Bank debt	€ 0 Bank debt 2022: € 0 First fiscal year in the series	€ 0 Bank debt 2023: € 0 Unchanged (€ 0) Unchanged	€ 80,755 Bank debt 2024: € 80,755 Unchanged (€ 0) Unfavourable step	€ 262,190 Bank debt 2025: € 262,190 ▲ 225% vs 2024 (€ 80,755) Unfavourable step	▲ 225%
Balance sheet total	€ 854,569 Balance sheet total 2022: € 854,569 First fiscal year in the series	€ 876,447 Balance sheet total 2023: € 876,447 ▲ 3% vs 2022 (€ 854,569) Unchanged	€ 1,196,745 Balance sheet total 2024: € 1,196,745 ▲ 37% vs 2023 (€ 876,447) Unchanged	€ 1,152,292 Balance sheet total 2025: € 1,152,292 ▼ 4% vs 2024 (€ 1,196,745) Unchanged	▼ 4%
Employees (FTE)	6.9 Employees (FTE) 2022: 6.9 First fiscal year in the series	7.9 Employees (FTE) 2023: 7.9 ▲ 1 vs 2022 (6.9) Unchanged	9.1 Employees (FTE) 2024: 9.1 ▲ 1.2 vs 2023 (7.9) Unchanged	11.4 Employees (FTE) 2025: 11.4 ▲ 2.3 vs 2024 (9.1) Unchanged	▲ 2.3

Key figures of DERMPAT, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to DERMPAT?

What happened at DERMPAT in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

May 20, 2026 New annual accounts for financial year 2025: profit of € 46,857 (▼ 75% vs 2024). Source: NBB ↗
2026 Nessence BV became a director. NBB
2025 Integron BV became a director. NBB
Apr 18, 2017 New establishment in Gent. KBO
Dec 22, 2011 Start of the company according to the CBE. KBO

In short

From € 64,738 profit in 2022 to € 46,857 profit in 2025.

Paid € 83,907 in corporate taxes since 2022.

Best year ever: 2024, with € 184,668 profit.

On average € 92,400 of value added per employee in 2025.

Original PDFs at the National Bank ↗

Management

Dr. Karolien Van Den Bossche 33.4%

Patholem 33.3%

INTEGRON 33.3%

The stake of Dr. Karolien Van Den Bossche, Patholem, INTEGRON comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

DERMPAT

Behind DERMPAT are Integron BV, Nessence BV, Patholem BV and Dr. Karolien Van Den Bossche BV. The shares are held by Dr. Karolien Van Den Bossche (33.4%), Patholem (33.3%) and INTEGRON (33.3%).

Directors

According to the 2025 annual accounts

Integron BV

Director · represented by Laura Gadeyne

since 2025

Nessence BV

Director · represented by Eveline Naessens-Foucquaert

since 2026

Patholem BV

Managing director · represented by Julie Lemahieu

Dr. Karolien Van Den Bossche BV

Director · represented by Karolien Van Den Bossche

Shareholders

Dr. Karolien Van Den Bossche

33.4%

Patholem

33.3%

INTEGRON

33.3%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Koning Albertlaan 210

9000 Gent

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.

All companies at this address →

MDUTR

€ 148,011 gross margin · 2025

MEDISCH LABO DERMPAT

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0842.445.493

VAT number

BE 0842.445.493

Registered office

Koning Albertlaan 210, 9000 Gent

Names & denominations

DERMPAT

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

22 December 2011

Peppol

Active · Active since 2 Sept 2025

Activities · NACE

Activiteiten van medisch specialisten

Activiteiten van medische beeldvorming en medische laboratoria

Verhuur en exploitatie van eigen of geleased niet-residentieel onroerend goed, exclusief terreinen

View on CBE Public ↗ Annual accounts (NBB) ↗

DERMPAT

Financials

What happened to DERMPAT?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions